103 related articles for article (PubMed ID: 26337774)
1. Role of nucleotides in stabilization of the phospholamban/cardiac Ca²⁺ pump inhibitory complex examined with use of metal fluorides.
Chen Z
FEBS J; 2015 Nov; 282(22):4402-14. PubMed ID: 26337774
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2010 Jan; 285(5):3253-60. PubMed ID: 19948724
[TBL] [Abstract][Full Text] [Related]
3. Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.
Akin BL; Chen Z; Jones LR
J Biol Chem; 2010 Sep; 285(37):28540-52. PubMed ID: 20622261
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain.
Chen Z; Akin BL; Stokes DL; Jones LR
J Biol Chem; 2006 May; 281(20):14163-72. PubMed ID: 16554295
[TBL] [Abstract][Full Text] [Related]
5. Competitive displacement of wild-type phospholamban from the Ca2+-free cardiac calcium pump by phospholamban mutants with different binding affinities.
Chen Z
J Mol Cell Cardiol; 2014 Nov; 76():130-7. PubMed ID: 25194792
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
7. Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum.
Chen Z; Stokes DL; Jones LR
J Biol Chem; 2005 Mar; 280(11):10530-9. PubMed ID: 15644311
[TBL] [Abstract][Full Text] [Related]
8. Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking.
Jones LR; Cornea RL; Chen Z
J Biol Chem; 2002 Aug; 277(31):28319-29. PubMed ID: 12015326
[TBL] [Abstract][Full Text] [Related]
9. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP
Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986
[TBL] [Abstract][Full Text] [Related]
10. Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.
Chen Z; Stokes DL; Rice WJ; Jones LR
J Biol Chem; 2003 Nov; 278(48):48348-56. PubMed ID: 12972413
[TBL] [Abstract][Full Text] [Related]
11. Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.
Akin BL; Jones LR
J Biol Chem; 2012 Mar; 287(10):7582-93. PubMed ID: 22247554
[TBL] [Abstract][Full Text] [Related]
12. Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate.
Waggoner JR; Huffman J; Froehlich JP; Mahaney JE
Biochemistry; 2007 Feb; 46(7):1999-2009. PubMed ID: 17261028
[TBL] [Abstract][Full Text] [Related]
13. The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.
Akin BL; Hurley TD; Chen Z; Jones LR
J Biol Chem; 2013 Oct; 288(42):30181-30191. PubMed ID: 23996003
[TBL] [Abstract][Full Text] [Related]
14. A phospholamban-tethered cardiac Ca2+ pump reveals stoichiometry and dynamic interactions between the two proteins.
Chen Z
Biochem J; 2011 Oct; 439(2):313-9. PubMed ID: 21728996
[TBL] [Abstract][Full Text] [Related]
15. Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state.
Espinoza-Fonseca LM; Autry JM; Thomas DD
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):37-41. PubMed ID: 25983321
[TBL] [Abstract][Full Text] [Related]
16. Phospholamban inhibits the cardiac calcium pump by interrupting an allosteric activation pathway.
Cleary SR; Seflova J; Cho EE; Bisht K; Khandelia H; Espinoza-Fonseca LM; Robia SL
J Biol Chem; 2024 May; 300(5):107267. PubMed ID: 38583863
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca
Fernández-de Gortari E; Espinoza-Fonseca LM
J Biol Chem; 2018 Aug; 293(32):12405-12414. PubMed ID: 29934304
[TBL] [Abstract][Full Text] [Related]
18. Atomic-level mechanisms for phospholamban regulation of the calcium pump.
Espinoza-Fonseca LM; Autry JM; Ramírez-Salinas GL; Thomas DD
Biophys J; 2015 Apr; 108(7):1697-1708. PubMed ID: 25863061
[TBL] [Abstract][Full Text] [Related]
19. Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.
Stroik DR; Ceholski DK; Bidwell PA; Mleczko J; Thanel PF; Kamdar F; Autry JM; Cornea RL; Thomas DD
J Mol Cell Cardiol; 2020 Jan; 138():59-65. PubMed ID: 31751570
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF).
Bovo E; Jamrozik T; Kahn D; Karkut P; Robia SL; Zima AV
Cell Calcium; 2024 Jul; 121():102910. PubMed ID: 38823350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
